Related Experiment Video

Updated: Dec 9, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.5K

Silencing ARAF Suppresses the Malignant Phenotypes of Gallbladder Cancer Cells

Weiguo Lin1,2, Chenhao Tong1, Weiguang Zhang3

  • 1Department of Hepatobiliary Surgery, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, China.

Biomed Research International
|September 14, 2020
PubMed

Insights

ARAF oncogene drives gallbladder cancer (GBC) progression. Silencing ARAF inhibited GBC cell growth and invasion, revealing ARAF as a potential therapeutic target for this common biliary tract tumor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • ARAF, a RAF kinase family member, is crucial for mitogen-activated protein kinase (MAPK) pathway activation in several cancers.
  • Gallbladder cancer (GBC) is the most common biliary tract malignancy, yet the role of ARAF in GBC remains unclear.

Purpose of the Study:

  • To investigate the function of ARAF in gallbladder cancer.
  • To determine if ARAF acts as an oncogene in GBC and explore its potential as a therapeutic target.

Main Methods:

  • Analyzed ARAF expression in GBC tissues.
  • Utilized RNA interference (RNAi) to silence ARAF in GBC cells in vitro.
  • Assessed the effects of ARAF silencing on cell proliferation, colony formation, migration, and invasion.
  • Evaluated the impact of ARAF knockdown on tumor growth in vivo.

Main Results:

  • ARAF expression was found to be upregulated in GBC tissues.
  • In vitro, ARAF silencing significantly inhibited GBC cell proliferation, colony formation, migration, and invasion.
  • In vivo, knockdown of ARAF suppressed tumor growth in GBC models.

Conclusions:

  • ARAF functions as an oncogene in gallbladder cancer.
  • ARAF plays a critical role in promoting GBC progression.
  • Targeting ARAF presents a potential therapeutic strategy for GBC treatment.

More Related Videos

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.3K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.7K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K